Home, Philip <br/><br/>
Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.  [electronic resource] 

 -  Diabetes care  May 2004 
 - 1081-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.27.5.1081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Glucose--metabolism<br/>Body Weight<br/>Diabetes Mellitus, Type 1--blood<br/>Female<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--agonists<br/>Insulin Detemir<br/>Insulin, Isophane--therapeutic use<br/>Insulin, Long-Acting<br/>Male